Literature DB >> 24575828

In vivo gene activity of human mesenchymal stem cells after scaffold-mediated local transplantation.

Soon Jung Hwang1, Tae Hyung Cho, In Sook Kim.   

Abstract

Functional activation of stem cells after transplantation is a main concern in stem cell therapy. For local transplantation, mesenchymal stem cells (MSCs) are usually administered via scaffolds, either by direct implantation or after preculturing of cells, and it is unclear which is better for the activation of transplanted cells. In this study, we investigated the in vivo gene expression activity of human MSCs (hMSCs) transplanted into calvarial defects either directly post-seeding on collagen sponges (Group 1) or after overnight in vitro culturing post-seeding (Group 2). Real-time reverse transcription-polymerase chain reaction at days 7 and 14 after transplantation identified a time-dependent, rapid decrease in gene expression by the hMSCs, which in Group 1 was slightly more attenuated than in Group 2. Both groups exhibited a limited range of human-specific gene expression, which involved type I collagen (ColI), fibronectin, stromal cell-derived factor (SDF-1), and osteoprotegerin. Among these, ColI expression was the most efficient, with higher levels in Group 1 than Group 2. There was a lack of evidence for the expression of osteoblast differentiation-related markers or trophic factors, while resident cells showed clear expression of those genes. Rat-specific β-actin expression in Group 2 was least among the scaffold control, Group 1, and Group 2, and this pattern was repeated in the expression of other rat osteogenic genes. Group 1 transplants positively influenced the osteogenic process of the defect tissue in part, and rat IGF-1 expression was significantly increased in Group 1. This tendency of gene expression by hMSCs in a rat model was very similar to what was observed in transplantations using immunodeficient mice. The current study showed that a main gene expressed by transplanted hMSCs during the initial weeks following transplantation is ColI, with a lack of differentiation-related markers or growth factor expression by hMSCs. Our data suggest that direct transplantation of hMSCs loaded on a collagen sponge is more efficient for gene activation in transplanted hMSCs, and more favorable to the local host tissue than transplantation after preculturing of cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24575828      PMCID: PMC4161061          DOI: 10.1089/ten.TEA.2013.0507

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  44 in total

1.  Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.

Authors:  T Kinnaird; E Stabile; M S Burnett; C W Lee; S Barr; S Fuchs; S E Epstein
Journal:  Circ Res       Date:  2004-01-22       Impact factor: 17.367

Review 2.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

3.  Interactions between human mesenchymal stem cells and natural killer cells.

Authors:  Panagiota A Sotiropoulou; Sonia A Perez; Angelos D Gritzapis; Constantin N Baxevanis; Michael Papamichail
Journal:  Stem Cells       Date:  2005-08-11       Impact factor: 6.277

Review 4.  Interactions between extracellular matrix and growth factors in wound healing.

Authors:  Gregory S Schultz; Annette Wysocki
Journal:  Wound Repair Regen       Date:  2009 Mar-Apr       Impact factor: 3.617

Review 5.  Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region.

Authors:  M Miura; Y Miura; W Sonoyama; T Yamaza; S Gronthos; S Shi
Journal:  Oral Dis       Date:  2006-11       Impact factor: 3.511

6.  Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice.

Authors:  P Niemeyer; J Vohrer; H Schmal; P Kasten; J Fellenberg; N P Suedkamp; A T Mehlhorn
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

7.  Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.

Authors:  Kiryo Wakabayashi; Atsushi Nagai; Abdullah Md Sheikh; Yuri Shiota; Dashdemberel Narantuya; Tatsuzo Watanabe; Junichi Masuda; Shotai Kobayashi; Seung U Kim; Shuhei Yamaguchi
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

8.  Bone marrow stromal cells enhance the angiogenesis in ischaemic cortex after stroke: involvement of notch signalling.

Authors:  Fei Guo; Shigang Lv; Yuanlei Lou; Wei Tu; Wei Liao; Yang Wang; Zhifeng Deng
Journal:  Cell Biol Int       Date:  2012-11-01       Impact factor: 3.612

9.  Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation.

Authors:  Edward J Caterson; Leon J Nesti; Keith G Danielson; Rocky S Tuan
Journal:  Mol Biotechnol       Date:  2002-03       Impact factor: 2.860

Review 10.  IGF-1 and bone: New discoveries from mouse models.

Authors:  Shoshana Yakar; Hayden-William Courtland; David Clemmons
Journal:  J Bone Miner Res       Date:  2010-12       Impact factor: 6.741

View more
  2 in total

1.  Substrate Microarchitecture Shapes the Paracrine Crosstalk of Stem Cells with Endothelial Cells and Osteoblasts.

Authors:  Francisco Martín-Saavedra; Lara Crespo; Clara Escudero-Duch; Laura Saldaña; Enrique Gómez-Barrena; Nuria Vilaboa
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

2.  Increased stem cells delivered using a silk gel/scaffold complex for enhanced bone regeneration.

Authors:  Xun Ding; Guangzheng Yang; Wenjie Zhang; Guanglong Li; Shuxian Lin; David L Kaplan; Xinquan Jiang
Journal:  Sci Rep       Date:  2017-05-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.